Family Planning Research

Reproductive Health Research

Our Division of Family Planning is dedicated to improving reproductive health through innovative research. We focus on enhancing telehealth contraception care, increasing access to contraceptive injections during COVID-19, expanding mifepristone use for early pregnancy loss, boosting referrals for medically complex patients, and studying Depot Medroxyprogesterone Acetate (DMPA) use in women with epilepsy. These efforts aim to provide comprehensive and equitable reproductive health solutions.

Improving Reproductive Health for All

Faculty in our Division of Family Planning are involved in various innovative research projects that seek to improve reproductive health. Below is a summary describing the priorities and focus of our investigations.

• Increase patient-centeredness of telehealth care for contraception
• Improve patient access for contraceptive injections during the COVID-19 pandemic
• Expand and evaluate the use of mifepristone for early pregnancy loss
• Increase referrals for medically complex patients
• Examine Depot Medroxyprogesterone Acetate (injectable contraceptive) use in women with epilepsy